Your session is about to expire
← Back to Search
Exercise and Nutrition for Head and Neck Cancers
N/A
Recruiting
Led By Sylvia Crowder, PhD
Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
No documented or observable psychiatric or neurological disorders that would interfere with study participation (e.g., dementia, psychosis)
>18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Study Summary
This trial will help develop an exercise and diet plan to improve the health of people with head and neck cancers.
Who is the study for?
The ENHANCE Study is for adults over 18 with new diagnoses of oral, oropharyngeal, hypopharyngeal, or laryngeal cancers. Participants must be able to eat orally, speak and read English, have no major psychiatric disorders, and be cleared for physical activity. They should not be pregnant or scheduled for surgery and must consent to a Mediterranean diet.Check my eligibility
What is being tested?
This study tests an intervention combining exercise with a special diet versus just the dietary change alone in head and neck cancer patients. The goal is to design a program that improves health outcomes by integrating physical activity and nutrition.See study design
What are the potential side effects?
Since this trial focuses on exercise and nutrition rather than medication, side effects may include muscle soreness from physical activity or changes in digestion due to dietary adjustments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I do not have any mental health conditions that would prevent me from participating.
Select...
I am over 18 years old.
Select...
My cancer is newly diagnosed and located in my mouth or throat.
Select...
I am scheduled for radiation or combined chemotherapy and radiation treatment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of Participants Recruited - Feasibility
Number of Participants who Complete Questionnaire - Retention - Feasibility
Number of Participants who Complete Task/Goals - Adherence
+5 moreTrial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: ENHANCE Intervention Diet and ExceriseExperimental Treatment1 Intervention
Participants will participate in 2 in-person supervised resistance training sessions every week for the 7 weeks (during radiation), followed by 2 ZOOM video conference supervised resistance training sessions every week for 5 weeks (after radiation). During radiation, participants will be provided 15 meals each week for 7 weeks. Participants will also attend weekly dietary coaching sessions. Participants will receive a Fitbit to wear continuously 24/7 over 12-weeks to track steps and activity intensity.
Group II: ENHANCE Intervention Diet OnlyExperimental Treatment1 Intervention
Participants will be provided 15 meals each week for 7 weeks that will accommodate common NIS concerns (ex. dysphagia and difficulty chewing) following an aMED dietary pattern (5 breakfast, 5 lunch, and 5 dinner), will be taught proper portion size, and will be asked to record percentages of each meal consumed in a provided food journal, in addition to any outside meals, snacks, or nutritional supplements. They will be provided with dietary coaching weekly to discuss NIS, aMED diet compliance, and set weekly SMART goals. Following completion of chemoradiotherapy (5 weeks), participants will be provided dietary coaching weekly (in-person or via videoconference), discuss NIS, aMED diet compliance at home, and set weekly SMART goals (30 min). Participants will receive a Fitbit to wear continuously 24/7 over 12-weeks to track steps and activity intensity.
Group III: Usual Care + FitbitActive Control1 Intervention
Participants will receive handouts with diet and exercise education. Participants will receive a Fitbit to wear continuously 24/7 over 12-weeks to track steps and activity intensity.
Find a Location
Who is running the clinical trial?
H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor
542 Previous Clinical Trials
135,452 Total Patients Enrolled
Sylvia Crowder, PhDPrincipal InvestigatorMoffitt Cancer Center
1 Previous Clinical Trials
40 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently pregnant.You can eat food by mouth.I do not have any mental health conditions that would prevent me from participating.I am over 18 years old.My cancer is newly diagnosed and located in my mouth or throat.I am scheduled for surgery.My primary diagnosis is not head and neck cancer.I am receiving nutrition through a feeding tube or IV.I am scheduled for radiation or combined chemotherapy and radiation treatment.
Research Study Groups:
This trial has the following groups:- Group 1: ENHANCE Intervention Diet and Excerise
- Group 2: ENHANCE Intervention Diet Only
- Group 3: Usual Care + Fitbit
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment in this trial available to participants yet?
"Affirmative. Clinicaltrials.gov lists this medical trial as being open for recruiting, having been first posted on March 20th of 2023 and last edited April 4th of the same year. 40 people need to be enrolled from a single site."
Answered by AI
What is the aggregate quantity of participants participating in this experiment?
"Affirmative. According to clinicaltrials.gov, this medical trial — which was first posted on March 20th 2021 — is currently recruiting candidates for participation. This experiment necessitates the recruitment of 40 individuals from one location."
Answered by AI
Share this study with friends
Copy Link
Messenger